Ligand Pharmaceuticals | LGND - Ebitda





Ebitda Cambiamento Data
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
Baxter International USD -447M 873M 2025-12
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Enviri Corporation USD 70.13M 4.29M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD 6.3B 2.09B 2025-12
Pacira USD 40.24M 1.53M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Veracyte USD 42.8M 488K 2026-03